In contrast, the overexpression of the wild‐type NEK1 construct but not the kinase‐dead mutant (K33A) construct increased the IC50 of sunitinib in ccRCC cells (Figure 6G). Here, NEK1 is linked to nonpapillary renal cell carcinoma.